FDA approves risankizumab as a treatment for plaque psoriasis FDA, 판상 건선 치료제로 리산키주맙 승인
FDA approves risankizumab as a treatment for plaque psoriasis Reuters (4/23, Babu, Nair) reports that yesterday, “AbbVie Inc said” that the FDA has “approved its Skyrizi [risankizumab] drug as a treatment for plaque psoriasis.” According to Reuters, “The approval … Continued